Novanta (NASDAQ:NOVT - Get Free Report) will likely be announcing its Q3 2026 results after the market closes on Monday, November 9th. Analysts expect Novanta to post earnings of $0.9670 per share and revenue of $301.02 million for the quarter. Novanta has set its FY 2026 guidance at 3.680-3.740 EPS and its Q3 2026 guidance at 0.950-1.000 EPS. Interested persons can find conference call details on the company's upcoming Q3 2026 earnings report for the latest details on the call scheduled for Tuesday, November 10, 2026 at 8:00 AM ET.
Novanta (NASDAQ:NOVT - Get Free Report) last released its earnings results on Wednesday, August 5th. The technology company reported $0.89 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.83 by $0.06. Novanta had a return on equity of 10.83% and a net margin of 6.00%. The business had revenue of $265.81 million during the quarter, compared to the consensus estimate of $262.30 million. During the same period last year, the business posted $0.76 earnings per share. The business's revenue for the quarter was up 10.3% on a year-over-year basis. On average, analysts expect Novanta to post $3.70 EPS for the current fiscal year and $4.33 EPS for the next fiscal year.
Novanta Stock Performance
NASDAQ:NOVT opened at $145.76 on Monday. Novanta has a 1 year low of $98.27 and a 1 year high of $176.38. The company has a market cap of $5.51 billion, a price-to-earnings ratio of 93.44 and a beta of 1.71. The company has a debt-to-equity ratio of 0.12, a current ratio of 4.57 and a quick ratio of 3.79. The stock's 50 day simple moving average is $142.32 and its two-hundred day simple moving average is $142.34.
Analysts Set New Price Targets
Several equities analysts have recently commented on NOVT shares. Robert W. Baird set a $194.00 price target on shares of Novanta in a report on Friday, August 7th. Weiss Ratings restated a "hold (c-)" rating on shares of Novanta in a research note on Tuesday, October 13th. Wall Street Zen lowered Novanta from a "buy" rating to a "hold" rating in a research note on Saturday, October 24th. Finally, Zacks Research cut shares of Novanta from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, October 6th. One analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $194.00.
View Our Latest Analysis on Novanta
Novanta Company Profile
(
Get Free Report)
Novanta Inc is a technology company that develops and manufactures precision equipment and components used primarily in medical and advanced industrial applications. Its solutions are designed to support the movement, imaging, measurement and processing functions of complex equipment.
The company's products include photonics and laser components, precision motion-control systems, medical imaging and visualization technologies, and equipment used in minimally invasive and robotic surgery.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Novanta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novanta wasn't on the list.
While Novanta currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.